| 1 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 288).
|
| 2 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6792).
|
| 3 |
Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
|
| 4 |
ClinicalTrials.gov (NCT02250651) Safety and Efficacy of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension. U.S. National Institutes of Health.
|
| 5 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 298).
|
| 6 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6814).
|
| 7 |
Anaesthetic drugs: linking molecular actions to clinical effects. Curr Pharm Des. 2006;12(28):3665-79.
|
| 8 |
Clinical pipeline report, company report or official report of Mati therapeutics.
|
| 9 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6828).
|
| 10 |
Effect of 0.04% AR-13324, a ROCK, and norepinephrine transporter inhibitor, on aqueous humor dynamics in normotensive monkey eyes. J Glaucoma. 2015 Jan;24(1):51-4.
|
| 11 |
FDA Approved Drug Products from FDA Official Website. 2022. Application Number: 215092.
|
| 12 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 305).
|
| 13 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7451).
|
| 14 |
ClinicalTrials.gov (NCT02207621) A Double-masked Study of AR-13324 in Patients With Glaucoma and Ocular Hypertension. U.S. National Institutes of Health.
|
| 15 |
The effect of prostaglandin F2 alpha-1-isopropylester (PGF2 alpha-IE) on uveoscleral outflow. Prog Clin Biol Res. 1989;312:429-36.
|
| 16 |
ClinicalTrials.gov (NCT02341560) Phase II/III, Randomized, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Non Arteritic Anterior Ischemic Optic Neuropathy (NAION). U.S. National Institutes of Health.
|
| 17 |
ClinicalTrials.gov (NCT02558400) Double-masked Study of PG324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension.
|
| 18 |
ClinicalTrials.gov (NCT01110499) Safety and Efficacy of AGN-210961 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension. U.S. National Institutes of Health.
|
| 19 |
ClinicalTrials.gov (NCT02136940) Multiple Dose-parallel-group Study of AMA0076 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension. U.S. National Institutes of Health.
|
| 20 |
ClinicalTrials.gov (NCT01699464) A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months. U.S. National Institutes of Health.
|
| 21 |
ClinicalTrials.gov (NCT02250612) SYL040012, Treatment for Open Angle Glaucoma (SYLTAG). U.S. National Institutes of Health.
|
| 22 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800023041)
|
| 23 |
ClinicalTrials.gov (NCT02862938) Study of NT-501 Encapsulated Cell Therapy for Glaucoma Neuroprotection and Vision Restoration. U.S. National Institutes of Health.
|
| 24 |
IOP-Lowering Effect of ONO-9054, A Novel Dual Agonist of Prostanoid EP3 and FP Receptors, in Monkeys. Invest Ophthalmol Vis Sci. 2015 Apr;56(4):2547-52.
|
| 25 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001290)
|
| 26 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5816).
|
| 27 |
Clinical pipeline report, company report or official report of Ocular therapeutix.
|
| 28 |
Clinical pipeline report, company report or official report of Forsight vision5.
|
| 29 |
ClinicalTrials.gov (NCT01123785) A Dose-Escalation Study Designed to Evaluate the Tolerability, Safety, Pharmacokinetics (PK), and Efficacy of Chronic Topical Ocular Application of INO-8875 in AdultsWith Ocular Hypertension or Primary Open-Angle Glaucoma. U.S. National Institutes of Health.
|
| 30 |
ClinicalTrials.gov (NCT01528111) Study to Evaluate the Safety, Tolerability, and Efficacy of LX7101 in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension. U.S. National Institutes of Health.
|
| 31 |
ClinicalTrials.gov (NCT01410188) Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension. U.S. National Institutes of Health.
|
| 32 |
ClinicalTrials.gov (NCT00753168) Phase 1-2 Evaluation of OT-730 Eye Drops in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-Angle Glaucoma. U.S. National Institutes ofHealth.
|
| 33 |
ClinicalTrials.gov (NCT00846989) Efficacy, Tolerability and Safety of RKI983 (0.05% & 0.10%) vs Xalatan in Patients With POAG or Ocular Hypertension. U.S. National Institutes of Health.
|
| 34 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800033965)
|
| 35 |
Metabolism of the aldose reductase inhibitor ALO1567 in man. Br J Clin Pharmacol. 1991 Aug;32(2):221-7.
|
| 36 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800005642)
|
| 37 |
ClinicalTrials.gov (NCT00767793) A Placebo-Controlled Study of INS117548 Ophthalmic Solution in Subjects With Glaucoma (P08650). U.S. National Institutes of Health.
|
| 38 |
ClinicalTrials.gov (NCT00443924) Study of INS115644 Ophthalmic Solution in Subjects With Ocular Hypertension or Glaucoma. U.S. National Institutes of Health.
|
| 39 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000600)
|
| 40 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003472)
|
| 41 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003470)
|
| 42 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000369)
|
| 43 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800009043)
|
| 44 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800007108)
|
| 45 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000292)
|
| 46 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008736)
|
| 47 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800034972)
|
| 48 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800018945)
|
| 49 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003469)
|
| 50 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000261)
|
| 51 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800005323)
|
| 52 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800018805)
|
| 53 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 21).
|
| 54 |
The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.
|
| 55 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1503).
|
| 56 |
Dose-dependent pharmacokinetics of L-693,612, a carbonic anhydrase inhibitor, following oral administration in rats. Pharm Res. 1994 Mar;11(3):438-41.
|
| 57 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 29).
|
| 58 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 344).
|
| 59 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 343).
|
| 60 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 341).
|
| 61 |
Baculoviral IAP repeat-containing-4 protects optic nerve axons in a rat glaucoma model.Mol Ther. 2002 Jun;5(6):780-7. doi: 10.1006/mthe.2002.0608.
|
| 62 |
Apelin protects against NMDA-induced retinal neuronal death via an APJ receptor by activating Akt and ERK1/2, and suppressing TNF- expression in mice.J Pharmacol Sci. 2017 Jan;133(1):34-41. doi: 10.1016/j.jphs.2016.12.002. Epub 2016 Dec 24.
|
| 63 |
Expression of cell surface transmembrane carbonic anhydrase genes CA9 and CA12 in the human eye: overexpression of CA12 (CAXII) in glaucoma.J Med Genet. 2003 Apr;40(4):257-61. doi: 10.1136/jmg.40.4.257.
|
| 64 |
Synthesis of 1,2,4-triazole-5-on derivatives and determination of carbonic anhydrase II isoenzyme inhibition effects.Bioorg Chem. 2019 Mar;83:170-179. doi: 10.1016/j.bioorg.2018.10.042. Epub 2018 Oct 23.
|
| 65 |
Caveolin-1 modulates intraocular pressure: implications for caveolae mechanoprotection in glaucoma.Sci Rep. 2016 Nov 14;6:37127. doi: 10.1038/srep37127.
|
| 66 |
Common genetic variants associated with open-angle glaucoma.Hum Mol Genet. 2011 Jun 15;20(12):2464-71. doi: 10.1093/hmg/ddr120. Epub 2011 Mar 22.
|
| 67 |
P16INK4a Upregulation Mediated by SIX6 Defines Retinal Ganglion Cell Pathogenesis in Glaucoma.Mol Cell. 2015 Sep 17;59(6):931-40. doi: 10.1016/j.molcel.2015.07.027. Epub 2015 Sep 10.
|
| 68 |
Location of the internal carotid artery and ophthalmic artery segments for non-invasive intracranial pressure measurement by multi-depth TCD.Libyan J Med. 2017 Dec;12(1):1384290. doi: 10.1080/19932820.2017.1384290.
|
| 69 |
The effects of endothelium-specific CYP2J2 overexpression on the attenuation of retinal ganglion cell apoptosis in a glaucoma rat model.FASEB J. 2019 Oct;33(10):11194-11209. doi: 10.1096/fj.201900756R. Epub 2019 Jul 11.
|
| 70 |
Molecular clustering identifies complement and endothelin induction as early events in a mouse model of glaucoma.J Clin Invest. 2011 Apr;121(4):1429-44. doi: 10.1172/JCI44646. Epub 2011 Mar 7.
|
| 71 |
Validation of the structure-function correlation report from the heidelberg edge perimeter and spectral-domain optical coherence tomography.Int Ophthalmol. 2019 Mar;39(3):533-540. doi: 10.1007/s10792-018-0836-z. Epub 2018 Feb 2.
|
| 72 |
Ocular amyloid deposition in familial amyloidosis, Finnish: an analysis of native and variant gelsolin in Meretoja's syndrome.Invest Ophthalmol Vis Sci. 1994 Sep;35(10):3759-69.
|
| 73 |
Novel ocular findings in oculodentodigital dysplasia (ODDD): a case report and literature review.Ophthalmic Genet. 2019 Feb;40(1):54-59. doi: 10.1080/13816810.2019.1571616. Epub 2019 Feb 15.
|
| 74 |
Targeting neuronal gap junctions in mouse retina offers neuroprotection in glaucoma.J Clin Invest. 2017 Jun 30;127(7):2647-2661. doi: 10.1172/JCI91948. Epub 2017 Jun 12.
|
| 75 |
Matrix GLA protein function in human trabecular meshwork cells: inhibition of BMP2-induced calcification process.Invest Ophthalmol Vis Sci. 2006 Mar;47(3):997-1007. doi: 10.1167/iovs.05-1106.
|
| 76 |
Nonclassical Ligand-Independent Regulation of Go Protein by an Orphan Class C G-Protein-Coupled Receptor.Mol Pharmacol. 2019 Aug;96(2):233-246. doi: 10.1124/mol.118.113019. Epub 2019 Jun 12.
|
| 77 |
Continued exploration and tail approach synthesis of benzenesulfonamides containing triazole and dual triazole moieties as carbonic anhydrase I, II, IV and IX inhibitors.Eur J Med Chem. 2019 Dec 1;183:111698. doi: 10.1016/j.ejmech.2019.111698. Epub 2019 Sep 12.
|
| 78 |
Activation of 5-HT1A Receptors Promotes Retinal Ganglion Cell Function by Inhibiting the cAMP-PKA Pathway to Modulate Presynaptic GABA Release in Chronic Glaucoma.J Neurosci. 2019 Feb 20;39(8):1484-1504. doi: 10.1523/JNEUROSCI.1685-18.2018. Epub 2018 Dec 12.
|
| 79 |
Genome-wide association study of intraocular pressure identifies the GLCCI1/ICA1 region as a glaucoma susceptibility locus.Hum Mol Genet. 2013 Nov 15;22(22):4653-60. doi: 10.1093/hmg/ddt293. Epub 2013 Jul 7.
|
| 80 |
Combined effect of brain-derived neurotrophic factor and LINGO-1 fusion protein on long-term survival of retinal ganglion cells in chronic glaucoma.Neuroscience. 2009 Aug 18;162(2):375-82. doi: 10.1016/j.neuroscience.2009.04.075. Epub 2009 May 5.
|
| 81 |
Jnk2 deficiency increases the rate of glaucomatous neurodegeneration in ocular hypertensive DBA/2J mice.Cell Death Dis. 2018 Jun 13;9(6):705. doi: 10.1038/s41419-018-0705-8.
|
| 82 |
Variations in the myocilin gene in patients with open-angle glaucoma.Arch Ophthalmol. 2002 Sep;120(9):1189-97. doi: 10.1001/archopht.120.9.1189.
|
| 83 |
Poly(-caprolactone) nanocapsule carriers with sustained drug release: single dose for long-term glaucoma treatment.Nanoscale. 2017 Aug 17;9(32):11754-11764. doi: 10.1039/c7nr03221h.
|
| 84 |
Genotype-Phenotype Associations of IL6 and PRG4 With Conjunctival Fibrosis After Glaucoma Surgery.JAMA Ophthalmol. 2017 Nov 1;135(11):1147-1155. doi: 10.1001/jamaophthalmol.2017.3407.
|
| 85 |
Targeting the vascular-specific phosphatase PTPRB protects against retinal ganglion cell loss in a pre-clinical model of glaucoma.Elife. 2019 Oct 17;8:e48474. doi: 10.7554/eLife.48474.
|
| 86 |
Sphingosine-1-Phosphate (S1P)-Related Response of Human Conjunctival Fibroblasts After Filtration Surgery for Glaucoma.Invest Ophthalmol Vis Sci. 2017 Apr 1;58(4):2258-2265. doi: 10.1167/iovs.16-21288.
|
| 87 |
Recent advances in genetically modified animal models of glaucoma and their roles in drug repositioning.Br J Ophthalmol. 2019 Feb;103(2):161-166. doi: 10.1136/bjophthalmol-2018-312724. Epub 2018 Oct 26.
|
| 88 |
Association between a SLC23A2 gene variation, plasma vitamin C levels, and risk of glaucoma in a Mediterranean population.Mol Vis. 2011;17:2997-3004. Epub 2011 Nov 17.
|
| 89 |
PTGFR and SLCO2A1 Gene Polymorphisms Determine Intraocular Pressure Response to Latanoprost in Han Chinese Patients with Glaucoma.Curr Eye Res. 2016 Dec;41(12):1561-1565. doi: 10.3109/02713683.2016.1143013. Epub 2016 Jun 23.
|
| 90 |
Research progress on human genes involved in the pathogenesis of glaucoma (Review).Mol Med Rep. 2018 Jul;18(1):656-674. doi: 10.3892/mmr.2018.9071. Epub 2018 May 23.
|
| 91 |
TRPC5 regulates axonal outgrowth in developing retinal ganglion cells.Lab Invest. 2020 Feb;100(2):297-310. doi: 10.1038/s41374-019-0347-1. Epub 2019 Dec 16.
|
| 92 |
Mutations in DDX58, which encodes RIG-I, cause atypical Singleton-Merten syndrome. Am J Hum Genet. 2015 Feb 5;96(2):266-74. doi: 10.1016/j.ajhg.2014.11.019. Epub 2015 Jan 22.
|
| 93 |
Modulation of factors affecting optic nerve head astrocyte migration.Invest Ophthalmol Vis Sci. 2010 Aug;51(8):4096-103. doi: 10.1167/iovs.10-5177. Epub 2010 Apr 7.
|
| 94 |
Causative glaucoma treatment: promising targets and delivery systems.Drug Discov Today. 2019 Aug;24(8):1606-1613. doi: 10.1016/j.drudis.2019.03.017. Epub 2019 Mar 21.
|
| 95 |
Antiglaucomatous effects of the activation of intrinsic Angiotensin-converting enzyme 2.Invest Ophthalmol Vis Sci. 2013 Jun 21;54(6):4296-306. doi: 10.1167/iovs.12-11427.
|
| 96 |
Taurine Depletion Causes ipRGC Loss and Increases Light-Induced Photoreceptor Degeneration.Invest Ophthalmol Vis Sci. 2018 Mar 1;59(3):1396-1409. doi: 10.1167/iovs.17-23258.
|
| 97 |
BAX to basics: How the BCL2 gene family controls the death of retinal ganglion cells.Prog Retin Eye Res. 2017 Mar;57:1-25. doi: 10.1016/j.preteyeres.2017.01.002. Epub 2017 Jan 4.
|
| 98 |
Different contributions of autophagy to retinal ganglion cell death in the diabetic and glaucomatous retinas.Sci Rep. 2018 Sep 6;8(1):13321. doi: 10.1038/s41598-018-30165-7.
|
| 99 |
Inhibitive effect of TAK-242 on Tenon's capsule fibroblasts proliferation in rat eyes.Int J Ophthalmol. 2019 Nov 18;12(11):1699-1707. doi: 10.18240/ijo.2019.11.06. eCollection 2019.
|
| 100 |
An examination of the regulatory mechanism of Pxdn mutation-induced eye disorders using microarray analysis.Int J Mol Med. 2016 Jun;37(6):1449-56. doi: 10.3892/ijmm.2016.2572. Epub 2016 Apr 20.
|
| 101 |
A feed-forward regulation of endothelin receptors by c-Jun in human non-pigmented ciliary epithelial cells and retinal ganglion cells.PLoS One. 2017 Sep 22;12(9):e0185390. doi: 10.1371/journal.pone.0185390. eCollection 2017.
|
| 102 |
Up-regulated endogenous erythropoietin/erythropoietin receptor system and exogenous erythropoietin rescue retinal ganglion cells after chronic ocular hypertension.Cell Mol Neurobiol. 2008 Feb;28(2):317-29. doi: 10.1007/s10571-007-9155-z. Epub 2007 Jun 7.
|
| 103 |
Genome-wide association study of intraocular pressure uncovers new pathways to glaucoma.Nat Genet. 2018 Aug;50(8):1067-1071. doi: 10.1038/s41588-018-0176-y. Epub 2018 Jul 27.
|
| 104 |
Childhood glaucoma genes and phenotypes: Focus on FOXC1 mutations causing anterior segment dysgenesis and hearing loss.Exp Eye Res. 2020 Jan;190:107893. doi: 10.1016/j.exer.2019.107893. Epub 2019 Dec 11.
|
| 105 |
Computational analysis for GNAQ mutations: New insights on the molecular etiology of Sturge-Weber syndrome.J Mol Graph Model. 2017 Sep;76:429-440. doi: 10.1016/j.jmgm.2017.07.011. Epub 2017 Jul 29.
|
| 106 |
Design, synthesis and biological evaluation of novel ureido benzenesulfonamides incorporating 1,3,5-triazine moieties as potent carbonic anhydrase IX inhibitors.Bioorg Chem. 2019 Feb;82:117-122. doi: 10.1016/j.bioorg.2018.10.005. Epub 2018 Oct 5.
|
| 107 |
The Role of the IL-20 Subfamily in Glaucoma.Mediators Inflamm. 2016;2016:4083735. doi: 10.1155/2016/4083735. Epub 2016 Jan 20.
|
| 108 |
Exploring Serum Levels of Brain Derived Neurotrophic Factor and Nerve Growth Factor Across Glaucoma Stages.PLoS One. 2017 Jan 9;12(1):e0168565. doi: 10.1371/journal.pone.0168565. eCollection 2017.
|
| 109 |
Chronic and acute models of retinal neurodegeneration TrkA activity are neuroprotective whereas p75NTR activity is neurotoxic through a paracrine mechanism.J Biol Chem. 2010 Dec 10;285(50):39392-400. doi: 10.1074/jbc.M110.147801. Epub 2010 Oct 13.
|
| 110 |
Loss of Shp2 Rescues BDNF/TrkB Signaling and Contributes to Improved Retinal Ganglion Cell Neuroprotection.Mol Ther. 2019 Feb 6;27(2):424-441. doi: 10.1016/j.ymthe.2018.09.019. Epub 2018 Oct 4.
|
| 111 |
A promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonist.Purinergic Signal. 2018 Sep;14(3):271-284. doi: 10.1007/s11302-018-9614-7. Epub 2018 Jul 17.
|
| 112 |
Omidenepag isopropyl for the treatment of glaucoma and ocular hypertension.Drugs Today (Barc). 2019 Jun;55(6):377-384. doi: 10.1358/dot.2019.55.6.2984806.
|
| 113 |
Relationship between Sigma-1 receptor and BDNF in the visual system.Exp Eye Res. 2018 Feb;167:25-30. doi: 10.1016/j.exer.2017.10.012. Epub 2017 Oct 12.
|
| 114 |
Arundic Acid Increases Expression and Function of Astrocytic Glutamate Transporter EAAT1 Via the ERK, Akt, and NF-B Pathways.Mol Neurobiol. 2018 Jun;55(6):5031-5046. doi: 10.1007/s12035-017-0709-x. Epub 2017 Aug 15.
|
| 115 |
Differential Gamma-Synuclein Expression in Acute and Chronic Retinal Ganglion Cell Death in the Retina and Optic Nerve.Mol Neurobiol. 2020 Feb;57(2):698-709. doi: 10.1007/s12035-019-01735-1. Epub 2019 Aug 28.
|
| 116 |
SQSTM1 Mutations and Glaucoma.PLoS One. 2016 Jun 8;11(6):e0156001. doi: 10.1371/journal.pone.0156001. eCollection 2016.
|
| 117 |
Mutation of the melastatin-related cation channel, TRPM3, underlies inherited cataract and glaucoma. PLoS One. 2014 Aug 4;9(8):e104000. doi: 10.1371/journal.pone.0104000. eCollection 2014.
|
| 118 |
Loss of thioredoxin function in retinas of mice overexpressing amyloid .Free Radic Biol Med. 2012 Aug 1;53(3):577-88. doi: 10.1016/j.freeradbiomed.2012.04.010. Epub 2012 Apr 21.
|
| 119 |
Redox proteins thioredoxin 1 and thioredoxin 2 support retinal ganglion cell survival in experimental glaucoma.Gene Ther. 2009 Jan;16(1):17-25. doi: 10.1038/gt.2008.126. Epub 2008 Aug 14.
|
| 120 |
An integrative data mining approach to identifying adverse outcome pathway signatures.Toxicology. 2016 Mar 28;350-352:49-61. doi: 10.1016/j.tox.2016.04.004. Epub 2016 Apr 20.
|
| 121 |
Rapid Development of Glaucoma Via ITV Nonselective ANGPT 1/2 Antibody: A Potential Role for ANGPT/TIE2 Signaling in Primate Aqueous Humor Outflow.Invest Ophthalmol Vis Sci. 2019 Oct 1;60(13):4097-4108. doi: 10.1167/iovs.18-26349.
|
| 122 |
Asymmetry of Peak Thicknesses between the Superior and Inferior Retinal Nerve Fiber Layers for Early Glaucoma Detection: A Simple Screening Method.Yonsei Med J. 2018 Jan;59(1):135-140. doi: 10.3349/ymj.2018.59.1.135.
|
| 123 |
Systems genetics identifies a role for Cacna2d1 regulation in elevated intraocular pressure and glaucoma susceptibility.Nat Commun. 2017 Nov 24;8(1):1755. doi: 10.1038/s41467-017-00837-5.
|
| 124 |
Recent advances in the rational design and development of LIM kinase inhibitors are not enough to enter clinical trials.Eur J Med Chem. 2018 Jul 15;155:445-458. doi: 10.1016/j.ejmech.2018.06.016. Epub 2018 Jun 8.
|
| 125 |
Inflammasomes, the eye and anti-inflammasome therapy.Eye (Lond). 2018 Mar;32(3):491-505. doi: 10.1038/eye.2017.241. Epub 2017 Nov 24.
|
| 126 |
Neovascular glaucoma regulation by arylsulfonyl indoline-benzamide (ASIB) through targeting NF-kB signalling pathway.3 Biotech. 2019 Jun;9(6):211. doi: 10.1007/s13205-019-1730-8. Epub 2019 May 10.
|
| 127 |
Targeting P2X7 receptors as a means for treating retinal disease.Drug Discov Today. 2019 Aug;24(8):1598-1605. doi: 10.1016/j.drudis.2019.03.029. Epub 2019 Apr 4.
|
| 128 |
Pediatric primary calcific band keratopathy with or without glaucoma from biallelic SLC4A4 mutations.Ophthalmic Genet. 2018 Aug;39(4):425-427. doi: 10.1080/13816810.2018.1459738. Epub 2018 Apr 19.
|
| 129 |
Altered expression of 3 alpha-hydroxysteroid dehydrogenases in human glaucomatous optic nerve head astrocytes.Neurobiol Dis. 2003 Oct;14(1):63-73. doi: 10.1016/s0969-9961(03)00101-3.
|
| 130 |
GSTM1-null and GSTT1-active genotypes as risk determinants of primary open angle glaucoma among smokers.Int J Ophthalmol. 2018 Sep 18;11(9):1514-1520. doi: 10.18240/ijo.2018.09.14. eCollection 2018.
|
| 131 |
HSD18B7 Enzyme Assay Technique Using a Triple Quadrupole Mass Spectrometer.Methods Mol Biol. 2019;1996:155-159. doi: 10.1007/978-1-4939-9488-5_13.
|
| 132 |
Blood Levels of Tumor Necrosis Factor Alpha and Its Type 2 Receptor Are Elevated in Patients with Boston Type I Keratoprosthesis.Curr Eye Res. 2019 Jun;44(6):599-606. doi: 10.1080/02713683.2019.1568500. Epub 2019 Feb 4.
|
| 133 |
Axonal protection by Nmnat3 overexpression with involvement of autophagy in optic nerve degeneration.Cell Death Dis. 2013 Oct 17;4(10):e860. doi: 10.1038/cddis.2013.391.
|
| 134 |
Sequence variation at ANAPC1 accounts for 24% of the variability in corneal endothelial cell density.Nat Commun. 2019 Mar 20;10(1):1284. doi: 10.1038/s41467-019-09304-9.
|
| 135 |
Ex-PRESS implantation for different types of glaucoma.Int J Ophthalmol. 2019 Aug 18;12(8):1290-1297. doi: 10.18240/ijo.2019.08.09. eCollection 2019.
|
| 136 |
Working your SOCS off: The role of ASB10 and protein degradation pathways in glaucoma.Exp Eye Res. 2017 May;158:154-160. doi: 10.1016/j.exer.2016.06.003. Epub 2016 Jun 11.
|
| 137 |
A homozygous B3GAT3 mutation causes a severe syndrome with multiple fractures, expanding the phenotype of linkeropathy syndromes.Am J Med Genet A. 2015 Nov;167A(11):2691-6. doi: 10.1002/ajmg.a.37209. Epub 2015 Jun 18.
|
| 138 |
Expression of CXCL6 and BBS5 that may be glaucoma relevant genes is regulated by PITX2.Gene. 2016 Nov 15;593(1):76-83. doi: 10.1016/j.gene.2016.08.019. Epub 2016 Aug 9.
|
| 139 |
Downregulation of microRNA-149 in retinal ganglion cells suppresses apoptosis through activation of the PI3K/Akt signaling pathway in mice with glaucoma.Am J Physiol Cell Physiol. 2018 Dec 1;315(6):C839-C849. doi: 10.1152/ajpcell.00324.2017. Epub 2018 Sep 5.
|
| 140 |
Treatment of chronic and extreme ocular hypotension following glaucoma surgery with intraocular platelet-rich plasma: A case report.Eur J Ophthalmol. 2019 Jul;29(4):NP9-NP12. doi: 10.1177/1120672118803515. Epub 2018 Oct 7.
|
| 141 |
CDKN2B gene rs1063192 polymorphism decreases the risk of glaucoma.Oncotarget. 2017 Mar 28;8(13):21167-21176. doi: 10.18632/oncotarget.15504.
|
| 142 |
The WldS gene delays axonal but not somatic degeneration in a rat glaucoma model.Eur J Neurosci. 2008 Sep;28(6):1166-79. doi: 10.1111/j.1460-9568.2008.06426.x. Epub 2008 Sep 9.
|
| 143 |
Bioinformatics analysis to identify the differentially expressed genes of glaucoma.Mol Med Rep. 2015 Oct;12(4):4829-36. doi: 10.3892/mmr.2015.4030. Epub 2015 Jul 2.
|
| 144 |
Ocular manifestations of 22q11.2 microduplication.Ophthalmology. 2014 Jan;121(1):392-398. doi: 10.1016/j.ophtha.2013.06.040. Epub 2013 Aug 21.
|
| 145 |
Cochlin in the eye: functional implications.Prog Retin Eye Res. 2007 Sep;26(5):453-69. doi: 10.1016/j.preteyeres.2007.06.002. Epub 2007 Jun 22.
|
| 146 |
Extended association study of PLEKHA7 and COL11A1 with primary angle closure glaucoma in a Han Chinese population.Invest Ophthalmol Vis Sci. 2014 May 22;55(6):3797-802. doi: 10.1167/iovs.14-14370.
|
| 147 |
Activation of the NFAT-Calcium Signaling Pathway in Human Lamina Cribrosa Cells in Glaucoma.Invest Ophthalmol Vis Sci. 2018 Feb 1;59(2):831-842. doi: 10.1167/iovs.17-22531.
|
| 148 |
Distribution of COL8A2 and COL8A1 gene variants in Caucasian primary open angle glaucoma patients with thin central corneal thickness.Mol Vis. 2010 Oct 29;16:2185-91.
|
| 149 |
Disease-specific Preference-based Measure of Glaucoma Health States: HUG-5 Psychometric Validation.J Glaucoma. 2019 Jul;28(7):593-600. doi: 10.1097/IJG.0000000000001267.
|
| 150 |
Intravitreal injection of -crystallin B2 improves retinal ganglion cell survival in an experimental animal model of glaucoma.PLoS One. 2017 Apr 6;12(4):e0175451. doi: 10.1371/journal.pone.0175451. eCollection 2017.
|
| 151 |
No difference in genotype frequencies of polymorphisms of the nitric oxide pathway between Caucasian normal and high tension glaucoma patients.Mol Vis. 2012;18:2174-81. Epub 2012 Aug 7.
|
| 152 |
Effect of cytoglobin overexpression on extracellular matrix component synthesis in human tenon fibroblasts.Biol Res. 2019 Apr 16;52(1):23. doi: 10.1186/s40659-019-0229-4.
|
| 153 |
Copy number variations and primary open-angle glaucoma.Invest Ophthalmol Vis Sci. 2011 Sep 9;52(10):7122-33. doi: 10.1167/iovs.10-5606. Print 2011.
|
| 154 |
Dock3-NMDA receptor interaction as a target for glaucoma therapy.Histol Histopathol. 2017 Mar;32(3):215-221. doi: 10.14670/HH-11-820. Epub 2016 Sep 9.
|
| 155 |
MicroRNA-141-3p inhibits retinal neovascularization and retinal ganglion cell apoptosis in glaucoma mice through the inactivation of Docking protein 5-dependent mitogen-activated protein kinase signaling pathway.J Cell Physiol. 2019 Jun;234(6):8873-8887. doi: 10.1002/jcp.27549. Epub 2018 Dec 4.
|
| 156 |
Genetics of glaucoma.Hum Mol Genet. 2017 Aug 1;26(R1):R21-R27. doi: 10.1093/hmg/ddx184.
|
| 157 |
Neuroprotective and neuroregenerative effects of CRMP-5 on retinal ganglion cells in an experimental in vivo and in vitro model of glaucoma.PLoS One. 2019 Jan 23;14(1):e0207190. doi: 10.1371/journal.pone.0207190. eCollection 2019.
|
| 158 |
Integrated microarray analysis provided novel insights to the pathogenesis of glaucoma.Mol Med Rep. 2017 Dec;16(6):8735-8746. doi: 10.3892/mmr.2017.7711. Epub 2017 Oct 4.
|
| 159 |
Intraocular miR-211 exacerbates pressure-induced cell death in retinal ganglion cells via direct repression of FRS2 signaling.Biochem Biophys Res Commun. 2018 Sep 18;503(4):2984-2992. doi: 10.1016/j.bbrc.2018.08.082. Epub 2018 Aug 18.
|
| 160 |
Classification and Statistical Trend Analysis in Detecting Glaucomatous Visual Field Progression.J Ophthalmol. 2019 May 28;2019:1583260. doi: 10.1155/2019/1583260. eCollection 2019.
|
| 161 |
The atrial natriuretic peptide gene in patients with familial primary open-angle glaucoma.Biochem Biophys Res Commun. 1996 Jun 14;223(2):221-5. doi: 10.1006/bbrc.1996.0874.
|
| 162 |
Genetic association and gene-gene interaction of HAS2, HABP1 and HYAL3 implicate hyaluronan metabolic genes in glaucomatous neurodegeneration.Dis Markers. 2012;33(3):145-54. doi: 10.1155/2012/390539.
|
| 163 |
IL-38: A New Player in Inflammatory Autoimmune Disorders.Biomolecules. 2019 Aug 5;9(8):345. doi: 10.3390/biom9080345.
|
| 164 |
LncRNA NR_003923 promotes cell proliferation, migration, fibrosis, and autophagy via the miR-760/miR-215-3p/IL22RA1 axis in human Tenon's capsule fibroblasts.Cell Death Dis. 2019 Aug 7;10(8):594. doi: 10.1038/s41419-019-1829-1.
|
| 165 |
Compensatory Role of Inositol 5-Phosphatase INPP5B to OCRL in Primary Cilia Formation in Oculocerebrorenal Syndrome of Lowe.PLoS One. 2013 Jun 21;8(6):e66727. doi: 10.1371/journal.pone.0066727. Print 2013.
|
| 166 |
Roles of lumican and keratocan on corneal transparency.Glycoconj J. 2002 May-Jun;19(4-5):275-85. doi: 10.1023/A:1025396316169.
|
| 167 |
Down-regulated LAMA4 inhibits oxidative stress-induced apoptosis of retinal ganglion cells through the MAPK signaling pathway in rats with glaucoma.Cell Cycle. 2019 May;18(9):932-948. doi: 10.1080/15384101.2019.1593645. Epub 2019 Apr 19.
|
| 168 |
The LRRC8-mediated volume-regulated anion channel is altered in glaucoma.Sci Rep. 2019 Apr 1;9(1):5392. doi: 10.1038/s41598-019-41524-3.
|
| 169 |
Delineation of Novel Compound Heterozygous Variants in LTBP2 Associated with Juvenile Open Angle Glaucoma.Genes (Basel). 2018 Oct 30;9(11):527. doi: 10.3390/genes9110527.
|
| 170 |
Development of Targeted siRNA Nanocomplexes to Prevent Fibrosis in Experimental Glaucoma Filtration Surgery.Mol Ther. 2018 Dec 5;26(12):2812-2822. doi: 10.1016/j.ymthe.2018.09.004. Epub 2018 Sep 11.
|
| 171 |
SET binding factor 2 (SBF2) mutation causes CMT4B with juvenile onset glaucoma.Neurology. 2004 Aug 10;63(3):577-80. doi: 10.1212/01.wnl.0000133211.40288.9a.
|
| 172 |
A genome-wide association study of intra-ocular pressure suggests a novel association in the gene FAM125B in the TwinsUK cohort.Hum Mol Genet. 2014 Jun 15;23(12):3343-8. doi: 10.1093/hmg/ddu050. Epub 2014 Feb 11.
|
| 173 |
Microsatellite analysis of the GLC1B locus on chromosome 2 points to NCK2 as a new candidate gene for normal tension glaucoma.Br J Ophthalmol. 2008 Sep;92(9):1293-6. doi: 10.1136/bjo.2008.139980.
|
| 174 |
Neuroglobin Can Prevent or Reverse Glaucomatous Progression in DBA/2J Mice.Mol Ther Methods Clin Dev. 2017 Apr 27;5:200-220. doi: 10.1016/j.omtm.2017.04.008. eCollection 2017 Jun 16.
|
| 175 |
Investigating a downstream gene of Gpnmb using the systems genetics method.Mol Vis. 2019 Apr 23;25:222-236. eCollection 2019.
|
| 176 |
Whole exome sequencing identifies multiple diagnoses in congenital glaucoma with systemic anomalies.Clin Genet. 2016 Oct;90(4):378-82. doi: 10.1111/cge.12816. Epub 2016 Jul 12.
|
| 177 |
Association of NT-proANP Level in Plasma and Humor Aqueous with Primary Open-Angle Glaucoma.Curr Eye Res. 2017 Feb;42(2):233-236. doi: 10.1080/02713683.2016.1180397. Epub 2016 Oct 10.
|
| 178 |
Essential roles of mitochondrial biogenesis regulator Nrf1 in retinal development and homeostasis.Mol Neurodegener. 2018 Oct 17;13(1):56. doi: 10.1186/s13024-018-0287-z.
|
| 179 |
Fine mapping of new glaucoma locus GLC1M and exclusion of neuregulin 2 as the causative gene.Mol Vis. 2007 May 23;13:779-84.
|
| 180 |
Design and synthesis of novel benzenesulfonamide containing 1,2,3-triazoles as potent human carbonic anhydrase isoforms I, II, IV and IX inhibitors.Eur J Med Chem. 2018 Jul 15;155:545-551. doi: 10.1016/j.ejmech.2018.06.021. Epub 2018 Jun 8.
|
| 181 |
Detection of differentially expressed glycogenes in trabecular meshwork of eyes with primary open-angle glaucoma.Invest Ophthalmol Vis Sci. 2006 Apr;47(4):1491-9. doi: 10.1167/iovs.05-0736.
|
| 182 |
Role of CYP1B1, MYOC, OPTN, and OPTC genes in adult-onset primary open-angle glaucoma: predominance of CYP1B1 mutations in Indian patients.Mol Vis. 2007 Apr 30;13:667-76.
|
| 183 |
Proteomics implicates peptidyl arginine deiminase 2 and optic nerve citrullination in glaucoma pathogenesis.Invest Ophthalmol Vis Sci. 2006 Jun;47(6):2508-14. doi: 10.1167/iovs.05-1499.
|
| 184 |
Identification of genes involved in glaucoma pathogenesis using combined network analysis and empirical studies.Hum Mol Genet. 2019 Nov 1;28(21):3637-3663. doi: 10.1093/hmg/ddz222.
|
| 185 |
Association of Glaucoma-Related, Optical Coherence Tomography-Measured Macular Damage With Vision-Related Quality of Life.JAMA Ophthalmol. 2017 Jul 1;135(7):783-788. doi: 10.1001/jamaophthalmol.2017.1659.
|
| 186 |
Genomic locus modulating corneal thickness in the mouse identifies POU6F2 as a potential risk of developing glaucoma.PLoS Genet. 2018 Jan 25;14(1):e1007145. doi: 10.1371/journal.pgen.1007145. eCollection 2018 Jan.
|
| 187 |
PRDX6 attenuates oxidative stress- and TGFbeta-induced abnormalities of human trabecular meshwork cells.Free Radic Res. 2009 Sep;43(9):783-95. doi: 10.1080/10715760903062887. Epub 2009 Jul 1.
|
| 188 |
Heterozygous Meg2 Ablation Causes Intraocular Pressure Elevation and Progressive Glaucomatous Neurodegeneration.Mol Neurobiol. 2019 Jun;56(6):4322-4345. doi: 10.1007/s12035-018-1376-2. Epub 2018 Oct 12.
|
| 189 |
Joint optic disc and cup boundary extraction from monocular fundus images.Comput Methods Programs Biomed. 2017 Aug;147:51-61. doi: 10.1016/j.cmpb.2017.06.004. Epub 2017 Jun 23.
|
| 190 |
Relaxin 2 fails to lower intraocular pressure and to dilate retinal vessels in rats.Int Ophthalmol. 2019 Apr;39(4):847-851. doi: 10.1007/s10792-018-0884-4. Epub 2018 Mar 13.
|
| 191 |
Evidence for RPGRIP1 gene as risk factor for primary open angle glaucoma.Eur J Hum Genet. 2011 Apr;19(4):445-51. doi: 10.1038/ejhg.2010.217. Epub 2011 Jan 12.
|
| 192 |
Increased expression of serum amyloid A in glaucoma and its effect on intraocular pressure.Invest Ophthalmol Vis Sci. 2008 May;49(5):1916-23. doi: 10.1167/iovs.07-1104. Epub 2008 Jan 25.
|
| 193 |
Incidence and risk factors for post-penetrating keratoplasty glaucoma: A systematic review and meta-analysis.PLoS One. 2017 Apr 21;12(4):e0176261. doi: 10.1371/journal.pone.0176261. eCollection 2017.
|
| 194 |
ETX1 is over-expressed in the glaucomatous trabecular meshwork.Mol Vis. 2009 Oct 16;15:2061-7.
|
| 195 |
Co-variation of STI1 and WDR36/UTP21 alters cell proliferation in a glaucoma model.Mol Vis. 2011;17:1957-69. Epub 2011 Jul 19.
|
| 196 |
A novel gene (oculomedin) induced by mechanical stretching in human trabecular cells of the eye.Biochem Biophys Res Commun. 1999 Jun 7;259(2):349-51. doi: 10.1006/bbrc.1999.0797.
|
| 197 |
Tetramethylpyrazine nitrone protects retinal ganglion cells against N-methyl-d-aspartate-induced excitotoxicity.J Neurochem. 2017 May;141(3):373-386. doi: 10.1111/jnc.13970. Epub 2017 Mar 3.
|
| 198 |
Prostaglandin analogues and nitric oxide contribution in the treatment of ocular hypertension and glaucoma.Br J Pharmacol. 2019 Apr;176(8):1079-1089. doi: 10.1111/bph.14328. Epub 2018 May 24.
|
| 199 |
Staged ocular fornix reconstruction for glaucoma drainage device under neoconjunctiva at the time of Boston type 1 Keratoprosthesis implantation.Ocul Surf. 2019 Apr;17(2):336-340. doi: 10.1016/j.jtos.2019.01.010. Epub 2019 Feb 8.
|
| 200 |
Optic Nerve Lipidomics Reveal Impaired Glucosylsphingosine Lipids Pathway in Glaucoma.Invest Ophthalmol Vis Sci. 2019 Apr 1;60(5):1789-1798. doi: 10.1167/iovs.18-25802.
|
| 201 |
Association of a polymorphism in the BIRC6 gene with pseudoexfoliative glaucoma.PLoS One. 2014 Aug 13;9(8):e105023. doi: 10.1371/journal.pone.0105023. eCollection 2014.
|
| 202 |
Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies.Nat Genet. 2018 Sep;50(9):1335-1341. doi: 10.1038/s41588-018-0184-y. Epub 2018 Aug 13.
|
| 203 |
Analysis of CYP1B1 in pediatric and adult glaucoma and other ocular phenotypes.Mol Vis. 2016 Oct 17;22:1229-1238. eCollection 2016.
|
| 204 |
Whole-Exome Sequencing of Congenital Glaucoma Patients Reveals Hypermorphic Variants in GPATCH3, a New Gene Involved in Ocular and Craniofacial Development.Sci Rep. 2017 Apr 11;7:46175. doi: 10.1038/srep46175.
|
| 205 |
A multiethnic genome-wide association study of primary open-angle glaucoma identifies novel risk loci.Nat Commun. 2018 Jun 11;9(1):2278. doi: 10.1038/s41467-018-04555-4.
|
| 206 |
Mutation Survey of Candidate Genes and Genotype-Phenotype Analysis in 20 Southeastern Chinese Patients with Axenfeld-Rieger Syndrome.Curr Eye Res. 2018 Nov;43(11):1334-1341. doi: 10.1080/02713683.2018.1493129. Epub 2018 Jul 17.
|
| 207 |
Genome-wide association study identifies susceptibility loci for open angle glaucoma at TMCO1 and CDKN2B-AS1.Nat Genet. 2011 Jun;43(6):574-8. doi: 10.1038/ng.824. Epub 2011 May 1.
|
| 208 |
Changes in gene expression in experimental glaucoma and optic nerve transection: the equilibrium between protective and detrimental mechanisms.Invest Ophthalmol Vis Sci. 2007 Dec;48(12):5539-48. doi: 10.1167/iovs.07-0542.
|
| 209 |
Generation of a new mouse model of glaucoma characterized by reduced expression of the AP-2 and AP-2 proteins.Sci Rep. 2017 Sep 11;7(1):11140. doi: 10.1038/s41598-017-11752-6.
|
| 210 |
Changes in retinal aquaporin-9 (AQP9) expression in glaucoma.Biosci Rep. 2013 Apr 23;33(2):e00035. doi: 10.1042/BSR20130005.
|
| 211 |
Regulation of cell death and survival pathways in experimental glaucoma.Exp Eye Res. 2007 Aug;85(2):250-8. doi: 10.1016/j.exer.2007.04.011. Epub 2007 May 13.
|
| 212 |
Clarifying the role of ATOH7 in glaucoma endophenotypes.Br J Ophthalmol. 2014 Apr;98(4):562-6. doi: 10.1136/bjophthalmol-2013-304080. Epub 2014 Jan 23.
|
| 213 |
Calcineurin cleavage is triggered by elevated intraocular pressure, and calcineurin inhibition blocks retinal ganglion cell death in experimental glaucoma.Proc Natl Acad Sci U S A. 2005 Aug 23;102(34):12242-7. doi: 10.1073/pnas.0505138102. Epub 2005 Aug 15.
|
| 214 |
Does elevated intraocular pressure reduce retinal TRKB-mediated survival signaling in experimental glaucoma?.Exp Eye Res. 2009 Dec;89(6):921-33. doi: 10.1016/j.exer.2009.08.003. Epub 2009 Aug 14.
|
| 215 |
Expression-associated polymorphisms of CAV1-CAV2 affect intraocular pressure and high-tension glaucoma risk.Mol Vis. 2015 May 11;21:548-54. eCollection 2015.
|
| 216 |
Lack of Correlation between ASB10 and Normal-tension Glaucoma in a Population from the Republic of Korea.Curr Eye Res. 2020 Apr;45(4):521-525. doi: 10.1080/02713683.2019.1668949. Epub 2019 Oct 7.
|
| 217 |
Cystatin a, a potential common link for mutant myocilin causative glaucoma.PLoS One. 2012;7(5):e36301. doi: 10.1371/journal.pone.0036301. Epub 2012 May 15.
|
| 218 |
Genome-wide association and admixture analysis of glaucoma in the Women's Health Initiative.Hum Mol Genet. 2014 Dec 15;23(24):6634-43. doi: 10.1093/hmg/ddu364. Epub 2014 Jul 15.
|
| 219 |
Lack of association of polymorphisms in elastin with pseudoexfoliation syndrome and glaucoma.J Glaucoma. 2010 Sep;19(7):432-6. doi: 10.1097/IJG.0b013e3181c4b0fe.
|
| 220 |
Novel FBN1 mutation causes Marfan syndrome with bilateral ectopia lentis and refractory glaucoma.Eur J Ophthalmol. 2012 Jul-Aug;22(4):667-9. doi: 10.5301/ejo.5000070.
|
| 221 |
Childhood glaucoma in association with congenital disorder of glycosylation caused by mutations in fucosyltransferase 8.J AAPOS. 2019 Dec;23(6):351-352. doi: 10.1016/j.jaapos.2019.08.272. Epub 2019 Sep 30.
|
| 222 |
Polymorphic glutathione S-transferase M1 is a risk factor of primary open-angle glaucoma among Estonians.Exp Eye Res. 2000 Nov;71(5):447-52. doi: 10.1006/exer.2000.0899.
|
| 223 |
Diagnostic accuracy of macular ganglion cell-inner plexiform layer thickness for glaucoma detection in a population-based study: Comparison with optic nerve head imaging parameters.PLoS One. 2018 Jun 26;13(6):e0199134. doi: 10.1371/journal.pone.0199134. eCollection 2018.
|
| 224 |
Latent TGF- binding protein-2 is essential for the development of ciliary zonule microfibrils.Hum Mol Genet. 2014 Nov 1;23(21):5672-82. doi: 10.1093/hmg/ddu283. Epub 2014 Jun 6.
|
| 225 |
A single gene connects stiffness in glaucoma and the vascular system.Exp Eye Res. 2017 May;158:13-22. doi: 10.1016/j.exer.2016.08.022. Epub 2016 Sep 1.
|
| 226 |
The cost burden of falls in people with glaucoma in National Health Service Hospital Trusts in the UK.J Med Econ. 2020 Jan;23(1):106-112. doi: 10.1080/13696998.2019.1646262. Epub 2019 Aug 13.
|
| 227 |
Glaucoma-causing myocilin mutants require the Peroxisomal targeting signal-1 receptor (PTS1R) to elevate intraocular pressure.Hum Mol Genet. 2007 Mar 15;16(6):609-17. doi: 10.1093/hmg/ddm001. Epub 2007 Feb 22.
|
| 228 |
Evidence-Based Criteria for Determining Peripapillary OCT Reliability.Ophthalmology. 2020 Feb;127(2):167-176. doi: 10.1016/j.ophtha.2019.08.027. Epub 2019 Aug 29.
|
| 229 |
Variants in the PRPF8 Gene are Associated with Glaucoma.Mol Neurobiol. 2018 May;55(5):4504-4510. doi: 10.1007/s12035-017-0673-5. Epub 2017 Jul 13.
|
| 230 |
Localization of SH3PXD2B in human eyes and detection of rare variants in patients with anterior segment diseases and glaucoma.Mol Vis. 2012;18:705-13. Epub 2012 Mar 26.
|
| 231 |
Association of SIX1/SIX6 locus polymorphisms with regional circumpapillary retinal nerve fibre layer thickness: The Nagahama study.Sci Rep. 2017 Jun 29;7(1):4393. doi: 10.1038/s41598-017-02299-7.
|
| 232 |
A Common Glaucoma-risk Variant of SIX6 Alters Retinal Nerve Fiber Layer and Optic Disc Measures in a European Population: The EPIC-Norfolk Eye Study.J Glaucoma. 2018 Sep;27(9):743-749. doi: 10.1097/IJG.0000000000001026.
|
| 233 |
Mutations in the RNA granule component TDRD7 cause cataract and glaucoma. Science. 2011 Mar 25;331(6024):1571-6. doi: 10.1126/science.1195970.
|
| 234 |
The microfibril hypothesis of glaucoma: implications for treatment of elevated intraocular pressure.J Ocul Pharmacol Ther. 2014 Mar-Apr;30(2-3):170-80. doi: 10.1089/jop.2013.0184. Epub 2014 Feb 12.
|
| 235 |
Elevated Plasma Levels of Drebrin in Glaucoma Patients With Neurodegeneration.Front Neurosci. 2019 Apr 3;13:326. doi: 10.3389/fnins.2019.00326. eCollection 2019.
|
| 236 |
Analysis of the polymorphic variants of RAN and GEMIN3 genes and risk of Primary Open-Angle Glaucoma in the Polish population.Ophthalmic Genet. 2018 Apr;39(2):180-188. doi: 10.1080/13816810.2017.1381978. Epub 2017 Nov 2.
|
| 237 |
Functional analysis of FOXE3 mutations causing dominant and recessive ocular anterior segment disease.Hum Mutat. 2015 Mar;36(3):296-300. doi: 10.1002/humu.22741.
|
| 238 |
Loss of heterozygosity in pseudoexfoliation syndrome.Invest Ophthalmol Vis Sci. 1999 May;40(6):1255-60.
|
| 239 |
Clinical spectrum of pseudoexfoliation syndrome-An electronic records audit.PLoS One. 2017 Oct 27;12(10):e0185373. doi: 10.1371/journal.pone.0185373. eCollection 2017.
|
| 240 |
Genetic Variant Near PLXDC2 Influences the Risk of Primary Open-angle Glaucoma by Increasing Intraocular Pressure in the Japanese Population.J Glaucoma. 2017 Nov;26(11):963-966. doi: 10.1097/IJG.0000000000000790.
|
| 241 |
Dogs and humans share a common susceptibility gene SRBD1 for glaucoma risk.PLoS One. 2013 Sep 11;8(9):e74372. doi: 10.1371/journal.pone.0074372. eCollection 2013.
|
|
|
|
|
|
|
